| Press Release | BioDelivery Sciences Prevails in BELBUCA ANDA Litigation Maintaining Patent Exclusivity Against Alvogen Until 2032 | BioDelivery Sci... | 0 | 3 years 2 months ago |
| Press Release | BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences | BioDelivery Sci... | 0 | 3 years 2 months ago |
| Press Release | BioDelivery Sciences International to Host ELYXYB Investor Day | BioDelivery Sci... | 0 | 3 years 2 months ago |
| Press Release | More events are coming soon. | BioDelivery Sci... | 0 | 3 years 2 months ago |
| Press Release | BioDelivery Sciences Appoints John Golubieski as Chief Financial Officer | BioDelivery Sci... | 0 | 3 years 2 months ago |
| Press Release | BioDelivery Sciences Appoints Terry Coelho as Chief Financial Officer | BioDelivery Sci... | 0 | 6 years 3 weeks ago |
| Press Release | BioDelivery Announces Expanded Preferred Insurance Coverage For BELBUCA | BioDelivery Sci... | 0 | 6 years 3 weeks ago |
| Press Release | BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference | BioDelivery Sci... | 0 | 6 years 2 months ago |
| Press Release | BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference | BioDelivery Sci... | 0 | 6 years 2 months ago |
| Press Release | BioDelivery Sciences to Host Institutional Investor and Analyst Day on Friday | BioDelivery Sci... | 0 | 6 years 2 months ago |
| Press Release | BioDelivery Sciences Secures Significant Expanded Preferred Coverage for BELBUCA | BioDelivery Sci... | 0 | 6 years 2 months ago |
| Press Release | BioDelivery Sciences to Present at the Rodman & Renshaw 20th Annual Global Investment Conference | BioDelivery Sci... | 0 | 6 years 2 months ago |
| Press Release | BioDelivery Sciences Announces Changes to its Executive Leadership Team | BioDelivery Sci... | 0 | 6 years 2 months ago |
| Press Release | BioDelivery Sciences Announces Further Significant Expanded Preferred Coverage For BELBUCA | BioDelivery Sci... | 0 | 6 years 2 months ago |
| Press Release | BioDelivery Sciences Announces Ohio Workers Compensation Adding BELBUCA and BUNAVAIL to Formulary | BioDelivery Sci... | 0 | 7 years 4 months ago |
| Press Release | BioDelivery Sciences to Present at the 29th Annual Piper Jaffray Conference | BioDelivery Sci... | 0 | 7 years 4 months ago |
| Press Release | BioDelivery Sciences Announces Patent Litigation Settlement Agreement with Teva | BioDelivery Sci... | 0 | 7 years 5 months ago |
| Press Release | BioDelivery Sciences Participates in U.S. Department of Health and Human Services Round Table Discussion on Pain Management and Opioid Dependence | BioDelivery Sci... | 0 | 7 years 5 months ago |
| Press Release | BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2017 Healthcare Conference | BioDelivery Sci... | 0 | 7 years 6 months ago |
| Press Release | BioDelivery Sciences Announces Granting of Market Authorization Transfer by Health Canada for BELBUCA and Associated Milestone Payment | BioDelivery Sci... | 0 | 7 years 6 months ago |
| Press Release | BioDelivery Sciences Presents Data on BELBUCA (buprenorphine) Buccal Film at the PAINWeek 2017 Conference | BioDelivery Sci... | 0 | 7 years 6 months ago |
| Press Release | BioDelivery Sciences to Present at the Rodman & Renshaw 19th Annual Global Investment Conference | BioDelivery Sci... | 0 | 7 years 7 months ago |
| Press Release | BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman | BioDelivery Sci... | 0 | 7 years 7 months ago |
| Press Release | BioDelivery Sciences to Present Three Posters on BELBUCA and BUNAVAIL at PAINWeek 2017 | BioDelivery Sci... | 0 | 7 years 7 months ago |
| Press Release | BioDelivery Sciences Publishes Shareholder Letter with Mid-Year Corporate Update | BioDelivery Sci... | 0 | 7 years 8 months ago |
